Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "als pathophysiology"

ResearchRSSMay 12

ALS Pathophysiology

Scientists are still trying to understand exactly what causes ALS (a disease that weakens muscles over time). Researchers have identified many different problems that happen in the brains of people with ALS—like too much of a chemical called glutamate, broken energy-producing parts of cells, and inflammation—but they don't yet know which problem starts the disease or in what order these problems happen.

WHY IT MATTERSUnderstanding what actually triggers ALS is essential for developing treatments that address the root cause rather than just the symptoms, which could eventually lead to better ways to slow or stop the disease.
Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases